Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt

Covid19 Clinical Trial

Official title:

Survival and 30-days Hospital Outcome in Hospitalized COVID-19 Patients in Upper Egypt: Multi-center Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04488588
• Other study ID #: AssiutU17
• Status: Completed
• Start date: March 15, 2020
• Est. completion date: July 1, 2020

Study information

• Verified date: July 2020
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Through history, there have been plenty of pandemics however; the social response to corona virus disease (COVID-19) is unparalleled. It is assessed that almost four billion individuals are living in social segregation during this mother of all pandemics.

Initially described in China in December 2019, severe acute respiratory syndrome caused by corona virus 2 (SARS-CoV-2) has spread all over the world and by 18th July 2020- there was an emergent figure of 13,824,739 confirmed cases and 591.666 losses reported to the WHO. To date, Egypt reported slightly over 82,000 confirmed COVID-19 cases with 3858 deaths. The new pandemic is injuring not only health organizations of several countries but also the financial prudence universal.

Defining the clinical features and associated outcomes of patients diagnosed with coronavirus disease (COVID-19) is fundamental to improving our understanding and adequate management of this illness. Several articles have recently been published, describing the clinical features and outcomes of retrospective individuals with COVID-19

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1064
• Est. completion date: July 1, 2020
• Est. primary completion date: May 1, 2020
• Gender: All
• Age group: 36 Years to 63 Years

Eligibility

Inclusion Criteria:

• This study included 1064 patients consecutively admitted to isolation hospitals in Upper Egypt during the period from 22 March to 23 June 2020

Exclusion Criteria:

• only hospitalized confirmed cases of COVID-19 were included.

Related Conditions & MeSH terms

• Coronavirus Disease
• Coronavirus Infections
• Covid19
• SARS-CoV-2

Intervention

Other:
• Kaplan Meier analysis
Kaplan Meier survival analysis was conducted to calculate the cumulative overall survival rates using Log Rank test for comparison between age groups

Locations

Country	Name	City	State
Egypt	Aliae Mohamed-Hussein	Assiut
Egypt	AssiutU	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of co-morbidities in hospitalized patients with COVID-19	Determinants of survival in studied covid-19 patients admitted to hospitals	one month
Primary	causes of ICU admission	Determinants of ICU admission in hospitalized patients with COVID-19	one month